Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88.1M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
-241K
-
Total reported value, excl. options
-
$44.6M
-
Value change
-
-$1.24M
-
Number of buys
-
8
-
Number of sells
-
-11
-
Price
-
$4.12
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2020
29 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q1 2020.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 88.1M outstanding shares and own 12.3% of the company stock.
Largest 10 shareholders include 5AM Venture Management, LLC (3.46M shares), Canaan Partners X LLC (2.66M shares), BVF INC/IL (1.28M shares), PERCEPTIVE ADVISORS LLC (1.14M shares), BOXER CAPITAL, LLC (764K shares), Alphabet Inc. (753K shares), Point72 Asset Management, L.P. (198K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (174K shares), BAKER BROS. ADVISORS LP (127K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (85K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.